<DOC>
	<DOCNO>NCT00503399</DOCNO>
	<brief_summary>The objective study test hypothesis teriparatide superior active comparator change baseline 18 month lumbar spine volumetric trabecular bone mineral density ( BMD ) males glucocorticoid-induced osteoporosis .</brief_summary>
	<brief_title>Comparison Effects 2 Drugs Lumbar Spine Volumetric BMD Men With Glucocorticoid-Induced Osteoporosis</brief_title>
	<detailed_description>This study multinational , European , multicenter , randomize , open-label , active comparator control study 2 study period : screen phase 6 week , open-label treatment phase 18 month . Approximately 100 adult men osteoporosis associate sustain glucocorticoid therapy enrol study . Approximately one-half participant ( investigational site ) randomize teriparatide 20 micrograms/day ( ug/day give subcutaneous ( sc ) injection ) , half randomized risedronate 35 milligram ( mg ) weekly ( QW ) oral ( po ) tablet . All participant receive approximately 1000 mg/day elemental calcium 800 1200 international unit per day ( IU/day ) vitamin D .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Ambulatory men 25 year age old present Visit 1 bone mineral density ( BMD ) least 1.5 standard deviation ( SD ) correspond normal young adult men average BMD ( T score 1.5 low ) , determine manufacturer 's database follow region interest : total hip , femoral neck , lumbar spine Have receive glucocorticoid therapy average dose least 5.0 milligram ( mg ) per day prednisone equivalent minimum 3 consecutive month immediately precede screen ( Visit 1 ) , determine medical history . A minimum 2 lumbar vertebra ( L ) L1 L3 region must evaluable quantitative computerized tomography . Normal clinically insignificant abnormal laboratory value ( determine investigator ) include serum calcium , parathyroid hormone ( PTH ) ( 1 84 ) , 25 hydroxyvitamin D concentration , alkaline phosphatase activity . Presence mild , moderate , severe spinal fracture twelfth thoracic vertebra ( T12 ) first lumbar vertebra ( L1 ) , determined central read facility use semiquantitative technique . Abnormal albumincorrected serum calcium level History unresolved skeletal disease affect bone metabolism glucocorticoidinduced osteoporosis History malignant neoplasms 5 year prior Visit 2 , exception superficial basal cell squamous cell carcinoma skin definitively treat . Increased baseline risk osteosarcoma ; include patient Paget 's disease bone , previous primary skeletal malignancy , skeletal exposure therapeutic irradiation . Abnormal thyroid function correct therapy Past and/or current treatment certain medication .</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Glucocorticoid Induced</keyword>
</DOC>